S&P 500   4,171.49 (-0.81%)
DOW   32,776.20 (-0.81%)
QQQ   346.67 (-0.95%)
AAPL   178.39 (+0.61%)
MSFT   329.56 (-0.50%)
META   262.33 (-0.07%)
GOOGL   122.93 (-0.60%)
AMZN   119.28 (-1.96%)
TSLA   195.65 (-2.74%)
NVDA   385.49 (-3.89%)
NIO   7.18 (-3.10%)
BABA   77.91 (-0.97%)
AMD   119.66 (-4.48%)
T   15.78 (+0.90%)
F   12.01 (-4.61%)
MU   68.10 (-5.01%)
CGC   0.80 (-5.63%)
GE   100.09 (-2.26%)
DIS   87.22 (-0.68%)
AMC   4.45 (-3.89%)
PFE   37.79 (+2.11%)
PYPL   61.25 (-1.29%)
NFLX   393.39 (+0.10%)
S&P 500   4,171.49 (-0.81%)
DOW   32,776.20 (-0.81%)
QQQ   346.67 (-0.95%)
AAPL   178.39 (+0.61%)
MSFT   329.56 (-0.50%)
META   262.33 (-0.07%)
GOOGL   122.93 (-0.60%)
AMZN   119.28 (-1.96%)
TSLA   195.65 (-2.74%)
NVDA   385.49 (-3.89%)
NIO   7.18 (-3.10%)
BABA   77.91 (-0.97%)
AMD   119.66 (-4.48%)
T   15.78 (+0.90%)
F   12.01 (-4.61%)
MU   68.10 (-5.01%)
CGC   0.80 (-5.63%)
GE   100.09 (-2.26%)
DIS   87.22 (-0.68%)
AMC   4.45 (-3.89%)
PFE   37.79 (+2.11%)
PYPL   61.25 (-1.29%)
NFLX   393.39 (+0.10%)
S&P 500   4,171.49 (-0.81%)
DOW   32,776.20 (-0.81%)
QQQ   346.67 (-0.95%)
AAPL   178.39 (+0.61%)
MSFT   329.56 (-0.50%)
META   262.33 (-0.07%)
GOOGL   122.93 (-0.60%)
AMZN   119.28 (-1.96%)
TSLA   195.65 (-2.74%)
NVDA   385.49 (-3.89%)
NIO   7.18 (-3.10%)
BABA   77.91 (-0.97%)
AMD   119.66 (-4.48%)
T   15.78 (+0.90%)
F   12.01 (-4.61%)
MU   68.10 (-5.01%)
CGC   0.80 (-5.63%)
GE   100.09 (-2.26%)
DIS   87.22 (-0.68%)
AMC   4.45 (-3.89%)
PFE   37.79 (+2.11%)
PYPL   61.25 (-1.29%)
NFLX   393.39 (+0.10%)
S&P 500   4,171.49 (-0.81%)
DOW   32,776.20 (-0.81%)
QQQ   346.67 (-0.95%)
AAPL   178.39 (+0.61%)
MSFT   329.56 (-0.50%)
META   262.33 (-0.07%)
GOOGL   122.93 (-0.60%)
AMZN   119.28 (-1.96%)
TSLA   195.65 (-2.74%)
NVDA   385.49 (-3.89%)
NIO   7.18 (-3.10%)
BABA   77.91 (-0.97%)
AMD   119.66 (-4.48%)
T   15.78 (+0.90%)
F   12.01 (-4.61%)
MU   68.10 (-5.01%)
CGC   0.80 (-5.63%)
GE   100.09 (-2.26%)
DIS   87.22 (-0.68%)
AMC   4.45 (-3.89%)
PFE   37.79 (+2.11%)
PYPL   61.25 (-1.29%)
NFLX   393.39 (+0.10%)
Most-Upgraded StocksMost-Upgraded
NYSE:ZBH

Zimmer Biomet (ZBH) Stock Forecast, Price & News

$125.89
-0.54 (-0.43%)
(As of 11:45 AM ET)
Compare
Today's Range
$124.70
▼
$125.89
50-Day Range
$124.96
▼
$143.01
52-Week Range
$100.39
▼
$149.25
Volume
401,401 shs
Average Volume
1.38 million shs
Market Capitalization
$26.26 billion
P/E Ratio
58.83
Dividend Yield
0.76%
Price Target
$143.67
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Zimmer Biomet MarketRank™ Forecast

Analyst Rating
Hold
2.27 Rating Score
Upside/​Downside
14.7% Upside
$143.67 Price Target
Short Interest
Healthy
1.29% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
1.10mentions of Zimmer Biomet in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$2.87 M Sold Last Quarter
Proj. Earnings Growth
6.71%
From $7.45 to $7.95 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.89 out of 5 stars

Medical Sector

38th out of 1,006 stocks

Surgical Appliances & Supplies Industry

2nd out of 19 stocks

See Top Rated MarketRank™ Stocks Here

ZBH stock logo

About Zimmer Biomet (NYSE:ZBH) Stock

Zimmer Biomet Holdings Inc is a medical technology company that designs, develops and manufactures a wide range of orthopedic and musculoskeletal products. With headquarters in Warsaw, Indiana, the company was formed in 2015 after the merger of Zimmer Holdings and Biomet Inc, two of the world's leading companies in the orthopedic industry. Zimmer Biomet's mission is to help people alleviate pain, regain mobility and improve the quality of life for patients worldwide.

The company's leadership team is led by President and CEO Bryan Hanson, who has been in his current role since 2017. Hanson has over 30 years of experience in the medical device industry and has held various executive positions in leading medical device companies. Additionally, Zimmer Biomet's executive team includes Chief Financial Officer Suketu Upadhyay and Chief Operating Officer Ivan Tornos. 

Over the past few years, Zimmer Biomet has reported steady financial performance. The company has reported increased revenue and profit margin for the past several years while also reporting a debt-to-equity ratio indicating a relatively low debt level. In 2021, the company also announced a share repurchase program of up to $1 billion, demonstrating its commitment to returning value to shareholders.

Zimmer Biomet's stock performance has been mixed over the past few years. In early 2020, the company's stock price experienced a sharp decline due to the COVID-19 pandemic, but since then, it has rebounded and continues to experience volatility. 

The orthopedic industry is highly competitive, with a few major players dominating the market. Zimmer Biomet is one of the largest companies in the industry, with a strong presence in the joint reconstruction, spine, dental, and sports medicine markets. The industry is also highly regulated, with various regulatory bodies overseeing the safety and efficacy of medical devices. Zimmer Biomet has a track record of complying with regulatory requirements and maintaining high-quality standards.

Zimmer Biomet is expanding its product portfolio through innovation and acquisitions. The company has a robust pipeline of new products in development, including the Persona Revision Knee System and the ROSA Knee System. Zimmer Biomet is also pursuing strategic acquisitions to expand its presence in emerging markets and strengthen its position in existing markets.

One of the most significant risks facing Zimmer Biomet is the potential for regulatory changes that could impact the industry. Changes in regulatory requirements could increase the costs and time required to bring new products to market, affecting Zimmer Biomet's ability to innovate and compete. In addition, insurance and hospital reimbursement policy changes could also impact the demand for Zimmer Biomet's products.

Another risk facing Zimmer Biomet is the potential for increased competition. While the company is one of the most significant players in the orthopedic industry, it faces competition from other established companies and new entrants. To maintain its market position, Zimmer Biomet must continue to innovate and invest in research and development.

Finally, changes in consumer preferences and healthcare trends could impact demand for Zimmer Biomet's products. For example, the increasing popularity of non-surgical treatments for orthopedic conditions could affect the demand for joint replacement products.

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

May 31, 2023 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Globus Medical (GMED) and NuVasive (NUVA)
May 30, 2023 | finance.yahoo.com
Here's Why You Should Retain Integra (IART) Stock Now
May 31, 2023 | Edge On The Street (Ad)
Soaring EV Industry Keeps Investor Focus on Lithium
The need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.
May 30, 2023 | finance.yahoo.com
Down -8.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Zimmer (ZBH)
May 29, 2023 | finance.yahoo.com
ZBH vs. RMD: Which Stock Should Value Investors Buy Now?
May 26, 2023 | msn.com
Zimmer Biomet: Expect Growth Momentum To Continue
May 26, 2023 | finance.yahoo.com
Here's Why Investors Should Hold Encompass Health (EHC) Now
May 26, 2023 | americanbankingnews.com
Zacks Research Analysts Lift Earnings Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 31, 2023 | Edge On The Street (Ad)
Soaring EV Industry Keeps Investor Focus on Lithium
The need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.
May 21, 2023 | americanbankingnews.com
Truist Financial Trims Zimmer Biomet (NYSE:ZBH) Target Price to $147.00
May 21, 2023 | americanbankingnews.com
Stifel Nicolaus Raises Zimmer Biomet (NYSE:ZBH) Price Target to $165.00
May 21, 2023 | americanbankingnews.com
Brokerages Set Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Target Price at $141.50
May 19, 2023 | americanbankingnews.com
Zacks Research Equities Analysts Boost Earnings Estimates for Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 19, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Receives New Coverage from Analysts at StockNews.com
May 18, 2023 | nasdaq.com
Stifel Maintains Zimmer Biomet Holdings (ZBH) Buy Recommendation
May 15, 2023 | finance.yahoo.com
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2023
May 11, 2023 | americanbankingnews.com
Critical Contrast: Zimmer Biomet (NYSE:ZBH) & Heart Test Laboratories (NASDAQ:HSCS)
May 9, 2023 | marketwatch.com
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors
May 8, 2023 | finance.yahoo.com
Zacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet
May 7, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Given "Maintains" Rating at SpectralCast
May 6, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Lifted to "Strong-Buy" at StockNews.com
May 6, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $160.00
May 6, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $172.00
May 6, 2023 | americanbankingnews.com
Deutsche Bank Aktiengesellschaft Boosts Zimmer Biomet (NYSE:ZBH) Price Target to $147.00
May 6, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Raised to "Neutral" at Bank of America
May 6, 2023 | americanbankingnews.com
Raymond James Raises Zimmer Biomet (NYSE:ZBH) Price Target to $160.00
May 5, 2023 | americanbankingnews.com
Zimmer Biomet (NYSE:ZBH) Rating Increased to Neutral at FIG Partners
See More Headlines
Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Company Calendar

Ex-Dividend for 4/28 Dividend
3/28/2023
Dividend Payable
4/28/2023
Last Earnings
5/02/2023
Today
5/31/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:ZBH
Previous Symbol
NYSE:ZMH
CUSIP
N/A
CIK
1136869
Web
www.zimmerbiomet.com
Phone
(574) 267-6131
Fax
574-372-4988
Employees
18,000
Year Founded
1927

Price Target and Rating

Average Stock Price Forecast
$143.67
High Stock Price Forecast
$172.00
Low Stock Price Forecast
$112.00
Forecasted Upside/Downside
+13.6%
Consensus Rating
Hold
Rating Score (0-4)
2.27
Research Coverage
15 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$2.14
Trailing P/E Ratio
59.09
Forward P/E Ratio
16.97
P/E Growth
2.33
Net Income
$231.40 million
Net Margins
6.33%
Pretax Margin
8.29%
Return on Equity
12.43%
Return on Assets
7.09%

Debt

Debt-to-Equity Ratio
0.43
Current Ratio
1.89
Quick Ratio
0.93

Sales & Book Value

Annual Sales
$6.94 billion
Price / Sales
3.80
Cash Flow
$12.60 per share
Price / Cash Flow
10.04
Book Value
$58.29 per share
Price / Book
2.17

Miscellaneous

Outstanding Shares
208,570,000
Free Float
206,588,000
Market Cap
$26.38 billion
Optionable
Optionable
Beta
1.00

Social Links


Key Executives

  • Bryan C. HansonBryan C. Hanson
    Chairman, President & Chief Executive Officer
  • Ivan Tornos
    Chief Operating Officer
  • Suketu P. Upadhyay
    Chief Financial Officer & Executive Vice President
  • Zeeshan Tariq
    Chief Information Officer & Senior Vice President
  • Angela Main
    Chief Compliance Officer & Senior Vice President

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ZBH Stock - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 2 sell ratings, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings or view top-rated stocks.

What is Zimmer Biomet's stock price forecast for 2023?

15 Wall Street analysts have issued 12 month target prices for Zimmer Biomet's stock. Their ZBH share price forecasts range from $112.00 to $172.00. On average, they anticipate the company's share price to reach $143.67 in the next year. This suggests a possible upside of 13.6% from the stock's current price.
View analysts price targets for ZBH or view top-rated stocks among Wall Street analysts.

How have ZBH shares performed in 2023?

Zimmer Biomet's stock was trading at $127.50 at the beginning of the year. Since then, ZBH shares have decreased by 0.8% and is now trading at $126.46.
View the best growth stocks for 2023 here.

Are investors shorting Zimmer Biomet?

Zimmer Biomet saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 2,680,000 shares, a decrease of 17.3% from the April 30th total of 3,240,000 shares. Based on an average daily volume of 1,240,000 shares, the short-interest ratio is presently 2.2 days. Approximately 1.3% of the company's stock are short sold.
View Zimmer Biomet's Short Interest.

When is Zimmer Biomet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our ZBH earnings forecast.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) released its quarterly earnings data on Tuesday, May, 2nd. The medical equipment provider reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.25. The medical equipment provider had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.70 billion. Zimmer Biomet had a net margin of 6.33% and a trailing twelve-month return on equity of 12.43%. The business's quarterly revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the company earned $1.61 earnings per share.
Read the conference call transcript.

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Monday, May 15th. Investors of record on Monday, June 26th will be paid a dividend of $0.24 per share on Monday, July 31st. This represents a $0.96 annualized dividend and a dividend yield of 0.76%. The ex-dividend date of this dividend is Friday, June 23rd.
Read our dividend analysis for ZBH.

What ETFs hold Zimmer Biomet's stock?

ETFs with the largest weight of Zimmer Biomet (NYSE:ZBH) stock in their portfolio include Leatherback Long/Short Alternative Yield ETF (LBAY), American CenturyFocused Large Cap Value ETF (FLV), Simplify Health Care ETF (PINK), VanEck Morningstar Wide Moat ETF (MOAT), Goldman Sachs Future Health Care Equity ETF (GDOC), iShares U.S. Medical Devices ETF (IHI), FIS Biblically Responsible Risk Managed ETF (PRAY) and ALPS Hillman Active Value ETF (HVAL).

Is Zimmer Biomet a good dividend stock?

Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.75%. The dividend payout ratio is 44.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ZBH will have a dividend payout ratio of 12.08% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet updated its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $7.40-$7.50 for the period, compared to the consensus EPS estimate of $7.06. The company issued revenue guidance of $7.29 billion-$7.36 billion, compared to the consensus revenue estimate of $7.14 billion.

What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?

240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.07%), Price T Rowe Associates Inc. MD (5.00%), State Street Corp (4.19%), American Century Companies Inc. (2.42%), Dodge & Cox (2.36%) and Franklin Resources Inc. (2.10%). Insiders that own company stock include Arthur J Higgins, Chad F Phipps, Sang Yi and Zuilen Wilfred Van.
View institutional ownership trends.

How do I buy shares of Zimmer Biomet?

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $126.46.

How much money does Zimmer Biomet make?

Zimmer Biomet (NYSE:ZBH) has a market capitalization of $26.38 billion and generates $6.94 billion in revenue each year. The medical equipment provider earns $231.40 million in net income (profit) each year or $2.14 on an earnings per share basis.

How many employees does Zimmer Biomet have?

The company employs 18,000 workers across the globe.

Does Zimmer Biomet have any subsidiaries?
The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More
How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The official website for the company is www.zimmerbiomet.com. The medical equipment provider can be reached via phone at (574) 267-6131, via email at keri.mattox@zimmerbiomet.com, or via fax at 574-372-4988.

This page (NYSE:ZBH) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -